Skip to main content
WAY
NASDAQ Technology

Waystar Q3 Revenue Up 21% to $325.6M; FY26 Revenue Guidance $1.277B-$1.287B

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$28.14
Mkt Cap
$5.396B
52W Low
$17.26
52W High
$38.095
52W Position info
63% above low
Off High info
26% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

WAY sits 63% above its 52-week low of $17.26.

Summary

Waystar reported Q3 2026 revenue of $325.6M (up 21%) and adjusted EBITDA of $139.3M (43% margin), and guided FY2026 revenue to $1.277B-$1.287B with adjusted EBITDA of $543M-$549M.


Key Events · Earnings and Guidance · WAY

  • Q3 Revenue Grows 21% to $325.6M

    Revenue rose to $325.6M from $268.7M a year earlier, with subscription revenue up 34% to $180.7M and provider revenue up 28% to $243.4M.

  • Adjusted EBITDA $139.3M at 43% Margin

    Adjusted EBITDA of $139.3M produced a 42.8% margin, up from 42.0% a year ago; GAAP net income was $31.0M ($0.16 diluted) and non-GAAP net income $87.1M ($0.44 diluted).

  • FY2026 Guidance Issued

    Full-year 2026 revenue of $1.277B-$1.287B, adjusted EBITDA of $543M-$549M, non-GAAP net income of $322M-$337M and diluted non-GAAP EPS of $1.63-$1.71.

  • Cash Generation and Leverage

    Q3 operating cash flow was $103.9M and unlevered free cash flow $114.8M; net debt stood at $1.194B with an adjusted net leverage ratio of 2.2x.


Analysis · WAY · Technology

Waystar outpaced its own growth trajectory: revenue rose 21% to $325.6M while adjusted EBITDA margin held at 43%, and subscription revenue jumped 34% to $180.7M — the recurring, higher-quality piece of the business. Full-year 2026 guidance, issued for the first time in this release, points to $1.277B-$1.287B of revenue and $543M-$549M of adjusted EBITDA. Against a backdrop of steady insider selling under 10b5-1 plans (net $6.4M of open-market sales over 90 days), a clean quarter with expanding recurring revenue is the counterweight. The one blemish: GAAP net income margin slipped to 9.5% from 11.4% a year ago as stock-based compensation and acquisition costs rose, even though non-GAAP net income grew to $87.1M.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, WAY was trading at $28.14 on NASDAQ in the Technology sector, with a market capitalization of approximately $5.4B. The 52-week trading range was $17.26 to $38.10. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

WAY - Latest Insights

WAY
Nov 02, 2026, 4:05 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $28.14
Real-time Price: $27.54 info
Change: -$0.600 (-2%) info
Market Cap: $5.298B info
WAY
Nov 02, 2026, 4:02 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $28.14
Real-time Price: $27.54 info
Change: -$0.600 (-2%) info
Market Cap: $5.298B info
WAY
Jul 29, 2026, 4:29 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $22.50
Real-time Price: $27.54 info
Change: +$5.04 (+22%) info
Market Cap: $5.298B info
WAY
Jul 29, 2026, 4:04 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $24.52
Real-time Price: $27.54 info
Change: +$3.02 (+12%) info
Market Cap: $5.298B info
WAY
Jul 29, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $22.44
Real-time Price: $27.54 info
Change: +$5.10 (+23%) info
Market Cap: $5.298B info